Stockscreener 앱 받기
10.18
1.17%
-0.12
전일 마감가:
$10.30
열려 있는:
$10.34
하루 거래량:
34,101
Relative Volume:
0.72
시가총액:
$92.62M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
-5.04%
1개월 성능:
-12.24%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$10.18
$10.34
1주일 범위
$10.15
$10.54
52주 변동 폭
$9.62
$33.50
Research Alliance Corp Iii Stock (RACC) Company Profile
명칭
Research Alliance Corp Iii
전화
(617) 778-2500
주소
600 FIFTH AVENUE, 23RD FLOOR, NEW YORK
Compare RACC vs DMII, CCXI, EVAC, BCSS, CEPF
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RACC
Research Alliance Corp Iii
|
10.18 | 92.62M | 0 | 0 | 0 | 0.00 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.19 | 649.10M | 0 | 8.58M | -1.11M | 0.134 |
CCXI
Churchill Capital Corp Xi
|
10.93 | 608.80M | 37.20M | -133.09M | -26.53M | 0.0647 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.31 | 602.60M | 0 | 12.80M | -714.00K | 0.2184 |
BCSS
Bain Capital Gss Investment Corp
|
10.23 | 597.43M | 0 | 8.29M | -686.50K | 0.142 |
CEPF
Cantor Equity Partners Iv Inc
|
10.27 | 586.93M | 0 | 10.29M | -337.90K | 0.1801 |
Research Alliance Corp Iii 주식(RACC)의 최신 뉴스
Angelman drug partner for Research Alliance III (RACC) eyes 2029 data - Stock Titan
Sakana AI, SCSK, Sumitomo Corp forge Japan AI partnership - jp.ibtimes.com
Latus Bio Names Donald Hayden Chairman, Adds Michael MacLean to Board - citybiz
Health and care sector latest developments - The NHS Alliance
Research Alliance Corp II (RACB) Key Ratios - Value Research
Kazakhstan envisions at least 2.4 gigawatts of nuclear power by 2035. TGI Solar plans a tech base there. - Stock Titan
Research Alliance Corp II (RACB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Top Premarket Decliners - Moomoo
Research Alliance Corp II (RACB) Peer Comparison – Compare with Others - valueresearchonline.com
Lupus Research Alliance Awards More Than $2 Million to Study the Power of Lifestyle Interventions - Yahoo Finance
Research Alliance Holdings Iv Llc Net Worth (2026) - GuruFocus
Balyasny Asset Management L.P. Acquires 500,000 Shares of Resear - GuruFocus
Research Alliance Corp IV Q2 2026: Net income $(41,013), EPS $(0.03) — 10-Q Summary - TradingView
Research Alliance Corp IV (RACD) starts 24‑month clock to deploy $75M SPAC cash - Stock Titan
United Launch Alliance's new CEO and more leadership moves across the market - Washington Technology
RACD: Research Alliance Corporation IVInteractive ChartZacks.com - Zacks Investment Research
Research Alliance Corporation III (RACC) Institutional Ownership 2026 - MarketBeat
Research Alliance Corporation III (RACC) Earnings Date and Reports 2026 - MarketBeat
Research Alliance Corporation III Reports Earnings Results for the Four and Six Months Ended June 30, 2026 - marketscreener.com
Top Research Alliance Corporation III (RACC) Competitors 2026 - MarketBeat
Research Alliance Corporation III Class A Ordinary Shares (NASDAQ: RACC) Stock Price, News & Analysis - Kalkine
All News for RACD : Research Alliance Corporation IV - Zacks Investment Research
Research Alliance Corporation III Class A Ordinary Shares (NASDAQ: RACC) Stock Price, News & Analysis - kalkine.ca
8/3/2026 Market UpdateWinners: AEMD, HYFM, DFNSLosers: INHD, GYGY, CALCS&P 500: 1.5% - Trefis
AI Leaders Propose SAFE Guidelines for Cybersecurity Transparency - NVIDIA Blog
Should I buy Research Alliance Corporation IV (RACD) - Zacks Investment Research
What is the current Price Target and Forecast for Research Alliance Corporation III (RACC) - Zacks Investment Research
RACD Technical Analysis & Stock Price Forecast - Intellectia AI
7/30/2026 Market UpdateWinners: CYCU, GCTK, NUWELosers: MGRX, CCB, YYAIS&P 500: 1.7% - Trefis
PEMC, PERPI launch three-year research partnership on electricity market - Daily Tribune
Oak Hill takes SPAC track to Nasdaq with Roche asset in tow - BioSpace
OHB Pediatrics Ltd. entered into a definitive business combination agreement to acquire Research Alliance Corporation III from Research Alliance Holdings III LLC and others for approximately $160 million in a reverse merger transaction. - marketscreener.com
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC - fiercebiotech.com
OHB Pediatrics to go public through Research Alliance Corporation III pact - TipRanks
Oak Hill Bio goes public with ~$175M in proceeds - The Pharma Letter
RA Capital-backed SPAC Research Alliance Corp III agrees to merge with Oak Hill Bio in USD 175 million deal - Bitget
RA Capital-backed SPAC Research Alliance Corp III agrees to merge with Oak Hill Bio in USD 175 million deal - Bitget
Sierra Bancorp Q2 FY26 net income falls 7% to $9.9 million; revenue dips 1% to $39 million - Bitget
Iberdrola secures EUR 29 million EIB green loan for Labraza wind farm development - Bitget
Form 4 Research Alliance Corporation III For: 27 July By Investing.com - Investing.com Nigeria
EDGAR Filing Documents for 0001193125-26-316960 - SEC.gov
Form 4 Research Alliance Corporation III For: 27 July By Investing.com - Investing.com Canada
EDGAR Filing Documents for 0001193125-26-316954 - SEC.gov
Research Alliance to Acquire OHB Pediatrics in Stock Deal Valued at $160 Million Plus SAFEs - TradingView
Oak Hill Bio, Research Alliance III (RACC) plan SPAC merger - Stock Titan
Oak Hill Bio and Research Alliance Corporation III Announce - GlobeNewswire
Industry Leaders Unite in Open Secure AI Alliance for AI Safety and Security - NVIDIA Blog
Wilson Sonsini Advises Oak Hill Bio on IP Matters in Proposed Business Combination with RACC - Wilson Sonsini
RA Capital-backed SPAC Research Alliance Corp III agrees to merge with Oak Hill Bio in USD 175 million deal - Bitget
RACC|Research Alliance III Ord Shs Class A|Price:11.000|Chg%:-0.250 - TradingKey
Research Alliance Corp Iii (RACC) 재무 분석
Research Alliance Corp Iii (RACC)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.00%
자본화:
|
볼륨(24시간):